Literature DB >> 4456737

Impaired elimination of meperidine in patients with liver disease.

T S McHorse, U Klotz, G Wilkinson, S Schenker.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4456737

Source DB:  PubMed          Journal:  Trans Assoc Am Physicians        ISSN: 0066-9458


× No keyword cloud information.
  3 in total

Review 1.  Pharmacokinetics of opioids in liver disease.

Authors:  I Tegeder; J Lötsch; G Geisslinger
Journal:  Clin Pharmacokinet       Date:  1999-07       Impact factor: 6.447

2.  Patient-controlled analgesic therapy. Part I: Pharmacokinetics of pethidine in the per- and postoperative periods.

Authors:  A Tamsen; P Hartvig; C Fagerlund; B Dahlström
Journal:  Clin Pharmacokinet       Date:  1982 Mar-Apr       Impact factor: 6.447

Review 3.  Cholestasis and endogenous opioids: liver disease and exogenous opioid pharmacokinetics.

Authors:  Mellar Davis
Journal:  Clin Pharmacokinet       Date:  2007       Impact factor: 6.447

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.